Adalimumab in JIA-associated Uveitis Stopping Trial

Completed · Phase 4 · Has a placebo group

Conditions studied: Uveitis, JIA

In brief

The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA) or chronic anterior uveitis (CAU).

Key facts

Study ID
NCT03816397
Run by
Nisha Acharya
People needed
87
Starts
2020-03-15
Expected to finish
2025-04-03
Last updated by the study team
2025-05-11

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.